The 2020 World Congress on Controversies in Multiple Myeloma (COMy) was held virtually, on October 3–4. Experts in the field came together online to discuss and debate the latest controversies in the field.

Explore all the latest updates below!

View all videos

COMy 2020

Join us on for this upcoming IACH Journal Club
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
Tuesday, March 9, 2021 7 PM (Paris, Frankfurt)
Free Registration:https://register.gotowebinar.com/register/6435702555065190160
@Mohty_EBMT

Celebrating our UK experts for #BSW21

Hear from Gordan Cook (@LeedsHospitals) on trial designs for #Myeloma patients based on aging rather than age: http://ow.ly/nP6E50DQ1Wt

@WeHCScientists #NHS @ScienceWeekUK @BritSciAssoc #EMN21 #HemOnc #MultipleMyeloma #IAMRESILIENT2021 #MMSM

Its #Myeloma Action Month and this week we’re focusing on #mmMRD.

Hear from @NitinJainMD of @MDAndersonNews on how #MRD can improve patient outcomes:
💥http://ow.ly/DcH250DMTlU💥

#IAMRESILIENT2021 #ASH20 @ASH_hematology #HemOnc #mmMRD #MultipleMyeloma #MMSM

A great honor for me to lead Lymphoma portion of this trial. It is rare that a first-in-human phase 1 trial could be published in a high impact journal such as Lancet. It is another breakthrough attesting our unprecedented time, a time of accelerated science/biotech translation! https://twitter.com/viveksubbiah/status/1367849714163519490

Vivek Subbiah, MD@VivekSubbiah

Friday morning motivation 👉🏼Fantastic waterfall plots 👉🏼 Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study @OncoAlert https://twitter.com/viveksubbiah/status/1367681306063212553

Load More...

COMy 2020

The 2020 World Congress on Controversies in Multiple Myeloma (COMy) was held virtually, on October 3–4. Experts in the field came together online to discuss and debate the latest controversies in the field.

Explore all the latest updates below!

View all videos

Join us on for this upcoming IACH Journal Club
Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study
Tuesday, March 9, 2021 7 PM (Paris, Frankfurt)
Free Registration:https://register.gotowebinar.com/register/6435702555065190160
@Mohty_EBMT

Celebrating our UK experts for #BSW21

Hear from Gordan Cook (@LeedsHospitals) on trial designs for #Myeloma patients based on aging rather than age: http://ow.ly/nP6E50DQ1Wt

@WeHCScientists #NHS @ScienceWeekUK @BritSciAssoc #EMN21 #HemOnc #MultipleMyeloma #IAMRESILIENT2021 #MMSM

Its #Myeloma Action Month and this week we’re focusing on #mmMRD.

Hear from @NitinJainMD of @MDAndersonNews on how #MRD can improve patient outcomes:
💥http://ow.ly/DcH250DMTlU💥

#IAMRESILIENT2021 #ASH20 @ASH_hematology #HemOnc #mmMRD #MultipleMyeloma #MMSM

A great honor for me to lead Lymphoma portion of this trial. It is rare that a first-in-human phase 1 trial could be published in a high impact journal such as Lancet. It is another breakthrough attesting our unprecedented time, a time of accelerated science/biotech translation! https://twitter.com/viveksubbiah/status/1367849714163519490

Vivek Subbiah, MD@VivekSubbiah

Friday morning motivation 👉🏼Fantastic waterfall plots 👉🏼 Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study @OncoAlert https://twitter.com/viveksubbiah/status/1367681306063212553

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter